Page last updated: 2024-08-22

galactosamine and Liver Failure

galactosamine has been researched along with Liver Failure in 77 studies

Research

Studies (77)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	21 (27.27)	18.2507
2000's	36 (46.75)	29.6817
2010's	19 (24.68)	24.3611
2020's	1 (1.30)	2.80

Authors

Authors	Studies
Chen, L; Chen, X; Jiang, H; Li, L; Lv, L; Wang, K; Wang, Q; Yan, R	1
Bai, ZF; Cai, GM; Cui, HR; Han, JJ; Jiang, WY; Li, PY; Li, RS; Ma, X; Niu, M; Wang, JB; Wang, RL; Xiao, XH; Xu, GH; Zhang, CE; Zhang, LP	1
Canová, NK; Farghali, H; Hořínek, A; Lekić, N	1
Abshagen, K; Kuhla, A; Menger, MD; Norden, J; Vollmar, B	1
Bao, S; Cai, W; Gao, T; Li, H; Tabassam, F; Wang, H; Wu, H; Xiang, X; Xie, Q; Xu, Y; Zhao, G	1
Chen, YL; Li, XJ; Tang, NH; Wang, XQ; Zhang, FY	1
Cabrera-Pastor, A; Carda, C; Carratalá, A; Cauli, O; Duszczyk, M; Felipo, V; Gimenez-Garzó, C; González-Usano, A; Hernández-Rabaza, V; Lazarewicz, JW; López-Larrubia, P; Malek, M; Miguel, A; Montoliu, C; Ruiz-Sauri, A; Torregrosa, I; Urios, A	1
Fan, X; Huang, J; Shen, H; Wang, H; Zhang, B; Zhang, P; Zhong, B; Zhou, R	1
Hara, Y; Ikeda, T; Inoue, K; Kuroda, N; Sato, T; Wake, K	1
Chen, Y; Huang, Q; Huang, R; Liang, C; Liang, S; Lin, X; Lv, S; Wei, L; Wu, X; Zhang, S	1
Bai, L; Chen, Y; Duan, Z; Han, Y; Jiao, M; Ren, F; Shi, H; Wang, X; Wei, L; Wen, T; Zhang, J; Zhang, L; Zhang, X; Zhao, C; Zheng, S; Zhou, L	1
Brytan, M; Dyrla, P; Gil, J; Kade, G; Nowak, Z; Patera, J; Saracyn, M; Wańkowicz, Z; Zdanowski, R	1
Cho, HI; Choi, HS; Choi, JW; Hong, JM; Hwan Kwak, J; Kook Lee, S; Lee, DU; Lee, SM	1
El-Agamy, DS; Shaaban, AA; Shebl, AM	1
Kozłowski, W; Nowak, Z; Patera, J; Saracyn, M; Wańkowicz, Z; Wesołowski, P	1
Godes, M; Heiden, S; Hocher, B; Kalk, P; Pfab, T; Relle, K; Theuring, F; Vignon-Zellweger, N; von Websky, K; Zidek, W	1
Choi, JS; Heo, JH; Kang, SS; Kim, SH; Kim, YS; Lee, SM	1
Andres, T; Blei, MD; Cho, MD; Judy, R	1
Deng, H; Guo, HX; Liu, LM; Luo, J; Wang, XP; Zhang, JX	1
Bayrak, BB; Bolkent, S; Gezginci-Oktayoglu, S; Yanardag, R	1
Li, X; Lian, LH; Nan, JX; Wan, Y; Wu, YL; Xie, WX	1
Lian, LH; Nan, JX; Wan, Y; Wu, YL	1
Amresh, G; Rao, CV; Singh, S; Zeashan, H	1
Kim, KM; Kim, SJ; Kim, YS; Kwak, JH; Lee, SM; Park, J	1
Araya, S; Kawada, N; Nakamura, H; Okuyama, H; Shimahara, Y; Yamaoka, Y; Yodoi, J	1
Bradford, MA; Butler, NS; Hunninghake, GW; Monick, MM; Powers, LS; Yarovinsky, TO	1
Chamuleau, RA; Hoekstra, R; van de Kerkhove, MP; van Gulik, TM	1
Hwang, D; Lee, K; Stephanopoulos, G; Stephanopoulos, GN; Yarmush, ML; Yokoyama, T	1
Galle, PR; Herkel, J; Hermann, F; Lohse, AW; Schuchmann, M; van der Zee, R	1
Chen, P; Chen, YZ; Huang, HF; Wu, Y	1
Kim, YH; Lee, JJ; Lee, SH; Nam, JB; Nan, JX; Park, EJ; Sohn, DH; Zhao, YZ	1
Bajt, ML; Jaeschke, H	1
Kozłowski, W; Saracyn, M; Wańikowicz, Z	1
Imagawa, T; Kobayashi, N; Kobayashi, Y; Mori, M; Naruto, T; Sugai, T; Yokota, S	1
Banta, S; Berthiaume, F; Nagrath, D; Tompkins, RG; Yarmush, ML; Yokoyama, T	1
Hirao, Y; Kamiyama, Y; Kwon, AH; Okumura, T; Qiu, Z; Tsuji, K	1
Aoyagi, Y; Honda, Y; Ichida, T; Matsuda, Y; Suzuki, K; Takamura, M; Tamura, Y; Yamagiwa, S	1
Hijikawa, T; Kaibori, M; Kamiyama, Y; Matsui, K; Nishizawa, M; Okumura, T; Ozaki, T; Uchida, Y; Yamada, M	1
Anezaki, Y; Dohmen, T; Goto, T; Ishii, H; Kataoka, E; Ohnishi, H; Ohshima, S; Sato, W; Segawa, D; Shibuya, T; Takeuchi, S; Yamada, I; Yoneyama, K	1
Bae, K; Hung, TM; Kang, SS; Kim, SH; Kim, YS; Lee, SM	1
Dejager, L; Libert, C	1
Basile, AS; Mullen, K	1
Bohlinger, I; Gantner, F; Germann, PG; Leist, M; Tiegs, G; Wendel, A	1
Cyong, JC; Iijima, K; Kiyohara, H; Matsumoto, T; Tanaka, M; Yamada, H	1
Freudenberg, MA; Gantner, F; Germann, PG; Jilg, S; Leist, M; Tiegs, G	1
He, XS; Huang, JF; Xuan, WH	1
Hagihara, M; Munkhbat, B; Shimura, T; Takebe, K; Tsuji, K	1
Harada, A; Kimura, Y; Nakao, A; Nonami, T; Takagi, H; Taki, S; Yasui, M	1
Nakao, A; Taki, S	1
Gantner, F; Künstle, G; Küsters, S; Tiegs, G	1
Gantner, F; Uhlig, S; Wendel, A	1
Ede, RJ; Gove, CD; Hughes, RD; Williams, R	1
Adawi, D; Jeppsson, B; Kasravi, FB; Molin, G	1
Blumenthal, S; Diaz-Buxo, JA; Gordon, B; Gores, P; Hayes, D	1
Nyberg, SL	1
Carpenedo, R; Mannaioni, G; Moroni, F	1
Kalpana, K; Ong, HS; Prema Raj, J; Soo, KC; Tan, SY	1
Funakoshi, H; Kosai, K; Matsumoto, K; Nakamura, T	1
Hase, K; Kadota, S; Namba, T; Tezuka, Y; Xiong, Q	1
Hayes, PC; Nelson, LJ; Newsome, PN; Plevris, JN	1
Hiemstra, CA; IJzermans, JN; Marquet, RL; Meijer, R; Stockmann, HB	1
Galun, E; Pappo, O; Peters, M; Rose-John, S; Zeira, E	1
Bajt, ML; Cai, SX; Farhood, A; Jaeschke, H; Tseng, BY	1
De Freitas, LA; De Souza, VL; Pompeu, MM; Rao, VS; Santos, FA; Silva, RM; Teixeira, MJ; Tomé, AR	1
Hasuike, S; Hayashi, K; Hirono, S; Hori, T; Ido, A; Moriuchi, A; Nagata, K; Nakama, T; Tsubouchi, H	1
Arai, K; Berthiaume, F; Lee, K; Tompkins, RG; Yarmush, ML	1
Bhattacharyya, P; Datta, S	1
Balis, UJ; Shito, M; Tompkins, RG; Toner, M; Yarmush, ML	1
Bajt, ML; Jaeschke, H; Vonderfecht, SL	1
Filipponi, F; Mosca, F	1
Fujitani, S; Ishizaki-Koizumi, S; Nishiguchi, S; Sonaka, I	1
Abu-Jawdeh, G; Arvelo, MB; Cooper, JT; Czismadia, E; Daniel, S; Ferran, C; Grey, ST; Longo, C; Mahiou, J	1
Fan, ST; Ho, DW; Lau, C; To, J; Wong, J; Woo, YH; Zhang, Z	1
Horikawa, T; Nakazato, H; Oku, H; Suzuki, R; Tsuruta, Y	1
Hartung, T; Tiegs, G; Wendel, A	1
Li, BR; Lu, J; Ru, RP; Wu, XM; Zhang, BG	1
Chen, Y; Yang, WS; Yao, ZQ; Zhang, WB; Zhou, YX	1

Reviews

3 review(s) available for galactosamine and Liver Failure

Article	Year
Brain edema in acute liver failure. Insight from experimental studies. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 1990, Volume: 42 Suppl Topics: Animals; Brain Edema; Caprylates; Disease Models, Animal; Dogs; Galactosamine; Hepatectomy; Hepatic Artery; Hyperammonemia; Intracranial Hypertension; Ligation; Liver; Liver Failure; Portacaval Shunt, Surgical; Rabbits; Rats	1990
Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research. Biomaterials, 2004, Volume: 25, Issue:9 Topics: Acetaminophen; Animals; Disease Models, Animal; Dogs; Galactosamine; Guidelines as Topic; Hepatectomy; Liver; Liver Failure; Liver, Artificial; Research Design; Swine; Tissue Engineering	2004
Animal models of fulminant hepatic failure: a critical evaluation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:1 Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Disease Models, Animal; Dogs; Galactosamine; Humans; Liver Failure; Mice; Rabbits; Swine	2000

Other Studies

74 other study(ies) available for galactosamine and Liver Failure

Article	Year
Lactobacillus reuteri DSM 17938 alleviates d-galactosamine-induced liver failure in rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 133 Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Cytokines; Disease Models, Animal; Dysbiosis; Galactosamine; Gastrointestinal Microbiome; Ileum; Inflammation Mediators; Limosilactobacillus reuteri; Liver; Liver Failure; Male; Metabolome; Peroxisome Proliferator-Activated Receptors; Probiotics; Rats, Sprague-Dawley; Signal Transduction; Transcriptome	2021
A systems pharmacology-oriented discovery of a new therapeutic use of the TCM formula Liuweiwuling for liver failure. Scientific reports, 2018, 04-04, Volume: 8, Issue:1 Topics: Animals; Apoptosis; Databases, Factual; Drug Discovery; Drugs, Chinese Herbal; Galactosamine; Gene Regulatory Networks; Lipopolysaccharides; Liver Failure; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Signal Transduction; Systems Biology	2018
The involvement of heme oxygenase 1 but not nitric oxide synthase 2 in a hepatoprotective action of quercetin in lipopolysaccharide-induced hepatotoxicity of D-galactosamine sensitized rats. Fitoterapia, 2013, Volume: 87 Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Galactosamine; Heme Oxygenase-1; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Nitric Oxide Synthase; Nitrites; Phytotherapy; Plant Extracts; Quercetin; Rabbits; Rats; Rats, Wistar; RNA, Messenger; Transaminases	2013
RAGE blockade and hepatic microcirculation in experimental endotoxaemic liver failure. The British journal of surgery, 2013, Volume: 100, Issue:9 Topics: Animals; Antibodies; Endotoxemia; Fluorescent Antibody Technique; Galactosamine; Immunity, Innate; Lipopolysaccharides; Liver; Liver Circulation; Liver Failure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Systemic Inflammatory Response Syndrome; Up-Regulation	2013
Amelioration of liver injury by continuously targeted intervention against TNFRp55 in rats with acute-on-chronic liver failure. PloS one, 2013, Volume: 8, Issue:7 Topics: Animals; Galactosamine; Humans; Immunoglobulin Fc Fragments; Lipopolysaccharides; Liver; Liver Failure; Liver Failure, Acute; Rats; Rats, Wistar; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Serum Albumin; Tumor Necrosis Factor Decoy Receptors	2013
Therapeutic evaluation of a microbioartificial liver with recombinant HepG2 cells for rats with hepatic failure. Expert opinion on biological therapy, 2013, Volume: 13, Issue:11 Topics: Ammonia; Animals; Arginase; Bioreactors; Galactosamine; Hep G2 Cells; Humans; Implants, Experimental; Infusion Pumps, Implantable; Liver Failure; Liver, Artificial; Male; Miniaturization; Ornithine-Oxo-Acid Transaminase; Oxidation-Reduction; Random Allocation; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Urea	2013
Blocking NMDA receptors delays death in rats with acute liver failure by dual protective mechanisms in kidney and brain. Neuromolecular medicine, 2014, Volume: 16, Issue:2 Topics: Animals; Blood-Brain Barrier; Body Temperature; Brain; Brain Edema; Cerebrovascular Circulation; Disease Progression; Dizocilpine Maleate; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Galactosamine; Glomerular Filtration Rate; Hepatic Encephalopathy; Hyperammonemia; Intracranial Hypertension; Inulin; Kidney; Lactates; Liver Failure; Liver Regeneration; Male; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Time Factors	2014
Intraperitoneal administration of fetuin-A attenuates D-galactosamine/lipopolysaccharide-induced liver failure in mouse. Digestive diseases and sciences, 2014, Volume: 59, Issue:8 Topics: alpha-2-HS-Glycoprotein; Animals; Apoptosis; Disease Models, Animal; Female; Galactosamine; Injections, Intraperitoneal; Lipopolysaccharides; Liver; Liver Failure; Liver Function Tests; Mice; Mice, Inbred BALB C; Random Allocation; Tumor Necrosis Factor-alpha	2014
Apoptotic response through a high mobility box 1 protein-dependent mechanism in LPS/GalN-induced mouse liver failure and glycyrrhizin-mediated inhibition. PloS one, 2014, Volume: 9, Issue:4 Topics: Acetylation; Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Carrier Proteins; Dendritic Cells; Extracellular Space; Galactosamine; Gene Expression Regulation; Glutathione Transferase; Glycyrrhizic Acid; Histone Deacetylases; HMGB1 Protein; Kupffer Cells; Lipopolysaccharides; Liver Failure; Male; Mice, Inbred BALB C; Promoter Regions, Genetic; Protein Binding; Protein Transport; Receptor for Advanced Glycation End Products; RNA, Messenger; Time Factors; Toll-Like Receptor 4	2014
Protective effect of genistein on lipopolysaccharide/D-galactosamine- induced hepatic failure in mice. Biological & pharmaceutical bulletin, 2014, Volume: 37, Issue:4 Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Bilirubin; Carbon Monoxide; Caspase 3; Galactosamine; Genistein; Heme Oxygenase (Decyclizing); Lipid Peroxidation; Lipopolysaccharides; Liver Failure; Male; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Protective Agents; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor-alpha	2014
Peroxisome proliferator-activated receptor α activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway. Cell death & disease, 2014, Aug-28, Volume: 5 Topics: Acute Disease; Adenine; Adult; Animals; Autophagy; Autophagy-Related Protein 7; Cells, Cultured; Chemokines; Cytokines; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Female; Galactosamine; Hepatitis B; Hepatocytes; Humans; Inflammation; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver Failure; Macrophages; Male; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Middle Aged; Phosphorylation; PPAR alpha; Protective Agents; Pyrimidines; RNA Interference; RNA, Small Interfering; Toll-Like Receptor 4; Transcription Factor RelA	2014
D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure? Medical science monitor : international medical journal of experimental and clinical research, 2015, May-22, Volume: 21 Topics: Acute Kidney Injury; Alanine Transaminase; Albumins; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Creatinine; Disease Models, Animal; Galactosamine; Hepatocytes; Injections, Intraperitoneal; Liver Failure; Osmolar Concentration; Proteinuria; Rats; Rats, Sprague-Dawley; Specific Gravity; Statistics, Nonparametric; Urea	2015
β-Caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways. European journal of pharmacology, 2015, Oct-05, Volume: 764 Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cytokines; Cytoprotection; Disease Models, Animal; Galactosamine; Inflammation Mediators; Kupffer Cells; Lipopolysaccharides; Liver; Liver Failure; Male; Mice, Inbred ICR; Mitogen-Activated Protein Kinases; Polycyclic Sesquiterpenes; Receptor for Advanced Glycation End Products; Sesquiterpenes; Signal Transduction; Time Factors; Toll-Like Receptor 4	2015
Modulation of d-galactosamine/lipopolysacharride-induced fulminant hepatic failure by nilotinib. Human & experimental toxicology, 2018, Volume: 37, Issue:1 Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Aspartate Aminotransferases; Galactosamine; Interleukin-1beta; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; NF-kappa B; Pyrimidines; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2018
[Race of experimental animals and development of renal failure in animal model of hepatorenal syndrome]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2008, Volume: 24, Issue:142 Topics: Alanine Transaminase; Ammonia; Animals; Bilirubin; Disease Models, Animal; Galactosamine; Hepatocytes; Hepatorenal Syndrome; Kidney; Liver Failure; Male; Rats; Rats, Sprague-Dawley; Rats, Wistar; Renal Insufficiency	2008
Tissue specific activation of the endothelin system in severe acute liver failure. European journal of medical research, 2008, Jul-28, Volume: 13, Issue:7 Topics: Animals; Endothelins; Galactosamine; Inflammation; Kidney; Liver; Liver Failure; Male; Models, Biological; Necrosis; Rats; Rats, Sprague-Dawley; Tissue Distribution	2008
Protective effect of daidzin against D-galactosamine and lipopolysaccharide-induced hepatic failure in mice. Phytotherapy research : PTR, 2009, Volume: 23, Issue:5 Topics: Animals; Apoptosis; Caspase 3; Drugs, Chinese Herbal; Galactosamine; Glutathione; Hepatocytes; Isoflavones; Lipid Peroxidation; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred ICR; Mitochondrial Swelling; Oxidative Stress; Pueraria; Transaminases; Tumor Necrosis Factor-alpha	2009
Pim-3 protects against hepatic failure in D-galactosamine (D-GalN)-sensitized rats. European journal of clinical investigation, 2010, Volume: 40, Issue:2 Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Cytokines; Galactosamine; Lipopolysaccharides; Liver; Liver Failure; Male; Nitric Oxide Synthase Type II; Polymerase Chain Reaction; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; RNA, Messenger; Transaminases	2010
Z-FA.FMK activates duodenal epithelial cell proliferation through oxidative stress, NF-kappaB and IL-1beta in D-GalN/TNF-alpha-administered mice. Cell biology international, 2010, Apr-08, Volume: 34, Issue:5 Topics: Animals; Cell Proliferation; Cells, Cultured; Cysteine Proteinase Inhibitors; Dipeptides; Duodenum; Epithelial Cells; Galactosamine; Interleukin-1beta; Ketones; Liver Failure; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Oxidative Stress; Tumor Necrosis Factor-alpha	2010
Anti-apoptotic activity of gentiopicroside in D-galactosamine/lipopolysaccharide-induced murine fulminant hepatic failure. Chemico-biological interactions, 2010, Oct-06, Volume: 188, Issue:1 Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Blotting, Western; Caspases; Enzyme Activation; Galactosamine; Glucosides; Glutathione; Iridoid Glucosides; Iridoids; Lipid Peroxidation; Lipopolysaccharides; Liver Failure; Male; Mice; Mice, Inbred C57BL; Tumor Necrosis Factor-alpha	2010
Baicalein inhibits nuclear factor-κB and apoptosis via c-FLIP and MAPK in D-GalN/LPS induced acute liver failure in murine models. Chemico-biological interactions, 2010, Dec-05, Volume: 188, Issue:3 Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Cytochromes c; Cytoprotection; Disease Models, Animal; Flavanones; Galactosamine; Gene Expression Regulation, Enzymologic; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Proto-Oncogene Proteins c-bcl-2; Tumor Necrosis Factor-alpha; X-Linked Inhibitor of Apoptosis Protein	2010
Protective effect of Amaranthus spinosus against D-galactosamine/lipopolysaccharide-induced hepatic failure. Pharmaceutical biology, 2010, Volume: 48, Issue:10 Topics: Amaranthus; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Female; Galactosamine; India; Lipopolysaccharides; Liver; Liver Failure; Male; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley	2010
Geniposidic acid protects against D-galactosamine and lipopolysaccharide-induced hepatic failure in mice. Journal of ethnopharmacology, 2013, Mar-07, Volume: 146, Issue:1 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Fruit; Galactosamine; Gardenia; Glutathione; Heme Oxygenase-1; Interleukin-6; Iridoid Glucosides; Lipid Peroxidation; Lipopolysaccharides; Liver Failure; Male; Membrane Proteins; Mice; Mice, Inbred ICR; NF-E2-Related Factor 2; Phytotherapy; Plant Extracts; Protective Agents; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha	2013
Overexpression of thioredoxin prevents acute hepatitis caused by thioacetamide or lipopolysaccharide in mice. Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:5 Topics: Acute Disease; Animals; Antibodies; Apoptosis; Chemical and Drug Induced Liver Injury; Down-Regulation; fas Receptor; Galactosamine; Humans; Lipopolysaccharides; Liver Failure; Male; Mice; Mice, Inbred C57BL; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Survival Rate; Thioacetamide; Thioredoxins	2003
Adenoviral infection decreases mortality from lipopolysaccharide-induced liver failure via induction of TNF-alpha tolerance. Journal of immunology (Baltimore, Md. : 1950), 2003, Sep-01, Volume: 171, Issue:5 Topics: Adenovirus Infections, Human; Adenoviruses, Human; Animals; Antigens, CD; Autoantibodies; Cell Line; Disease Models, Animal; fas Receptor; Female; Galactosamine; Humans; Immune Tolerance; Injections, Intraperitoneal; Injections, Intravenous; Lipopolysaccharides; Liver; Liver Failure; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Survival Analysis; Tumor Necrosis Factor-alpha; Up-Regulation	2003
Identification of optimal classification functions for biological sample and state discrimination from metabolic profiling data. Bioinformatics (Oxford, England), 2004, Apr-12, Volume: 20, Issue:6 Topics: Algorithms; Amino Acids; Ammonia; Animals; Biomarkers; Diagnosis, Computer-Assisted; Galactosamine; Glucose; Ketone Bodies; Lactic Acid; Liver Failure; Male; Metabolic Clearance Rate; Models, Biological; Models, Statistical; Multivariate Analysis; Organ Specificity; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Urea	2004
HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cells. Immunology letters, 2004, May-15, Volume: 93, Issue:2-3 Topics: Alanine Transaminase; Animals; Cell Line; Cells, Cultured; Chaperonin 60; DNA-Binding Proteins; Female; Galactosamine; Gene Expression; Interleukin-6; Kupffer Cells; Lipopolysaccharides; Liver; Liver Failure; Macrophage Activation; Male; Mice; Oligodeoxyribonucleotides; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptor 4; Toll-Like Receptor 9; Tumor Necrosis Factor-alpha	2004
Recombinant fibronectin polypeptide antagonizes hepatic failure induced by endotoxin in mice. Acta pharmacologica Sinica, 2004, Volume: 25, Issue:6 Topics: Animals; Apoptosis; Cell Adhesion; Cells, Cultured; Cricetinae; Endotoxemia; Fibronectins; Galactosamine; Humans; Kidney; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred BALB C; Peptide Fragments; Recombinant Proteins	2004
Water-soluble polysaccharide from Eleutherococcus senticosus stems attenuates fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. Basic & clinical pharmacology & toxicology, 2004, Volume: 94, Issue:6 Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; DNA Fragmentation; Eleutherococcus; Galactosamine; Hepatocytes; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred Strains; Phytotherapy; Plant Extracts; Plant Stems; Polysaccharides; Protective Agents; Solubility; Tumor Necrosis Factor-alpha	2004
Critical role of CXC chemokines in endotoxemic liver injury in mice. Journal of leukocyte biology, 2004, Volume: 76, Issue:6 Topics: Animals; Antibodies; Apoptosis; Chemokine CXCL1; Chemokine CXCL2; Chemokines; Chemokines, CXC; Chemotaxis, Leukocyte; Cytokines; Disease Models, Animal; Endotoxemia; Endotoxins; Galactosamine; Liver Failure; Mice; Reproducibility of Results; Tumor Necrosis Factor-alpha	2004
[Description of an experimental model of hepatorenal syndrome in Wistar rats]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2004, Volume: 17, Issue:98 Topics: Alanine Transaminase; Ammonia; Animals; Aspartate Aminotransferases; Bilirubin; Disease Models, Animal; Galactosamine; Hepatocytes; Hepatorenal Syndrome; Kidney; Liver Failure; Male; Rats; Rats, Wistar	2004
Dynamic movement of cytochrome c from mitochondria into cytosol and peripheral circulation in massive hepatic cell injury. Pediatrics international : official journal of the Japan Pediatric Society, 2004, Volume: 46, Issue:6 Topics: Animals; Apoptosis; Biological Transport, Active; Blotting, Western; Cell Survival; Cells, Cultured; Cytochromes c; Cytosol; Disease Models, Animal; Female; Galactosamine; Hepatocytes; Immunohistochemistry; In Situ Nick-End Labeling; Lipopolysaccharides; Liver Failure; Mitochondria; Random Allocation; Rats; Rats, Wistar; Sensitivity and Specificity; Tumor Necrosis Factor-alpha	2004
Evolution of intrahepatic carbon, nitrogen, and energy metabolism in a D-galactosamine-induced rat liver failure model. Metabolic engineering, 2005, Volume: 7, Issue:2 Topics: Animals; Biomarkers; Carbon; Energy Metabolism; Galactosamine; In Vitro Techniques; Liver Failure; Male; Nitrogen; Perfusion; Rats; Rats, Sprague-Dawley	2005
Fibronectin prevents D-galactosamine/lipopolysaccharide-induced lethal hepatic failure in mice. Shock (Augusta, Ga.), 2006, Volume: 25, Issue:1 Topics: Animals; Apoptosis; bcl-X Protein; Cytokines; Female; Fibronectins; Galactosamine; Gene Expression Regulation; Hepatocytes; Lipopolysaccharides; Liver; Liver Failure; Mice; Mice, Inbred BALB C; Necrosis; NF-kappa B; Signal Transduction	2006
An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins. Life sciences, 2007, Mar-13, Volume: 80, Issue:14 Topics: Alanine Transaminase; Animals; Anthracenes; Apoptosis; Aspartate Aminotransferases; bcl-Associated Death Protein; BH3 Interacting Domain Death Agonist Protein; Disease Models, Animal; Down-Regulation; Drug Therapy, Combination; Enzyme Inhibitors; Galactosamine; Hepatocytes; Injections, Intraperitoneal; Injections, Subcutaneous; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver Failure; Longevity; Male; Mice; Mice, Inbred BALB C; Peptide Fragments; Proto-Oncogene Proteins	2007
Insulin-like growth factor 1 prevents liver injury through the inhibition of TNF-alpha and iNOS induction in D-galactosamine and LPS-treated rats. Shock (Augusta, Ga.), 2008, Volume: 29, Issue:6 Topics: Animals; Bilirubin; Enzyme Induction; Galactosamine; Humans; Insulin-Like Growth Factor I; Lipopolysaccharides; Liver; Liver Failure; Male; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; RNA Stability; RNA, Messenger; Transaminases; Tumor Necrosis Factor-alpha	2008
Mao (Ephedra sinica Stapf) protects against D-galactosamine and lipopolysaccharide-induced hepatic failure. Cytokine, 2008, Volume: 41, Issue:3 Topics: Animals; Apoptosis; Caspases; Cytokines; Disease Models, Animal; Ephedra sinica; Galactosamine; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL; Protein Kinase Inhibitors; STAT3 Transcription Factor; Tyrphostins	2008
Anti-apoptotic and hepatoprotective effects of gomisin A on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. Journal of pharmacological sciences, 2008, Volume: 106, Issue:2 Topics: Alanine Transaminase; Animals; Apoptosis; Caspase 3; Cyclooctanes; Dioxoles; DNA Fragmentation; Galactosamine; Glutathione; Lignans; Lipid Peroxidation; Lipopolysaccharides; Liver Failure; Male; Mice; Mice, Inbred ICR; Mitochondria, Liver; Mitochondrial Swelling; Oxidative Stress; Protective Agents; Tumor Necrosis Factor-alpha	2008
Tumor necrosis factor alpha mediates the lethal hepatotoxic effects of poly(I:C) in D-galactosamine-sensitized mice. Cytokine, 2008, Volume: 42, Issue:1 Topics: Animals; Antibodies; Chemical and Drug Induced Liver Injury; Female; Galactosamine; Humans; Hypothermia; Interferon Inducers; Lipopolysaccharides; Liver; Liver Failure; Mice; Mice, Inbred C57BL; Mice, Knockout; Poly I-C; Receptors, Tumor Necrosis Factor, Type I; Survival Rate; Toll-Like Receptors; Tumor Necrosis Factor Decoy Receptors; Tumor Necrosis Factor-alpha	2008
Preclinical models of hepatic encephalopathy. Current protocols in neuroscience, 2001, Volume: Chapter 9 Topics: Animals; Disease Models, Animal; Galactosamine; Hepatic Artery; Hepatic Encephalopathy; Hypertension, Portal; Ligation; Liver Failure; Male; Portacaval Shunt, Surgical; Postoperative Complications; Rats; Rats, Sprague-Dawley; Species Specificity; Suture Techniques; Thioacetamide	2001
Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. The American journal of pathology, 1995, Volume: 146, Issue:5 Topics: Animals; Apoptosis; Dactinomycin; DNA; Galactosamine; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Multiple Organ Failure; Proteins; RNA; Shock, Septic; Tumor Necrosis Factor-alpha	1995
Preventive effect of taraxasteryl acetate from Inula britannica subsp. japonica on experimental hepatitis in vivo. Planta medica, 1995, Volume: 61, Issue:1 Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Galactosamine; Inula; Liver Failure; Male; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Sterols; Triterpenes	1995
Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology, 1995, Volume: 109, Issue:1 Topics: Alanine Transaminase; Animals; Antibodies, Monoclonal; Apoptosis; CD3 Complex; DNA Damage; Enterotoxins; Galactosamine; Immunization; Liver; Liver Failure; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Shock; T-Lymphocytes; Tumor Necrosis Factor-alpha	1995
[The experimental study of the canine auxiliary partial liver transplantation for the liver failure]. Zhonghua wai ke za zhi [Chinese journal of surgery], 1994, Volume: 32, Issue:6 Topics: Animals; Dogs; Galactosamine; Liver Cirrhosis, Experimental; Liver Failure; Liver Transplantation; Male	1994
Beneficial effect of xenogeneic fetal liver fragment transplantation into a heterotopic subcutaneous omentum in acute liver failure in rats. Transplantation proceedings, 1994, Volume: 26, Issue:3 Topics: Alanine Transaminase; Animals; Fetal Tissue Transplantation; Galactosamine; Graft Survival; Liver Failure; Liver Transplantation; Male; Omentum; Rats; Rats, Wistar; Swine; Transplantation, Heterologous; Transplantation, Heterotopic	1994
The fate of intravenously injected endotoxin in normal rats and in rats with liver failure. Hepatology (Baltimore, Md.), 1994, Volume: 19, Issue:5 Topics: Animals; Endothelium; Endotoxins; Galactosamine; Immunohistochemistry; Injections, Intravenous; Kupffer Cells; Liver; Liver Failure; Male; Metabolic Clearance Rate; Rats; Rats, Wistar; Tissue Distribution	1994
[Endotoxin-inactivating activity in normal and D-galactosamine induced liver failure rats]. Nihon Geka Gakkai zasshi, 1993, Volume: 94, Issue:12 Topics: Animals; Endotoxins; Galactosamine; Liver; Liver Failure; Male; Rats; Rats, Wistar	1993
Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology, 1996, Volume: 111, Issue:2 Topics: Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Concanavalin A; DNA Damage; Enterotoxins; Enzyme-Linked Immunosorbent Assay; Galactosamine; Immune Sera; Interferon-gamma; Liver; Liver Failure; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Recombinant Proteins; T-Lymphocytes; Transaminases; Tumor Necrosis Factor-alpha	1996
Quinine inhibits release of tumor necrosis factor, apoptosis, necrosis and mortality in a murine model of septic liver failure. European journal of pharmacology, 1995, Dec-27, Volume: 294, Issue:1 Topics: Animals; Apoptosis; DNA; Galactosamine; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred BALB C; Necrosis; Potassium Channels; Quinine; Rats; Salmonella; Sepsis; Tumor Necrosis Factor-alpha	1995
Regional cerebral edema and chloride space in galactosamine-induced liver failure in rats. Hepatology (Baltimore, Md.), 1997, Volume: 25, Issue:2 Topics: Acute Disease; Animals; Body Water; Brain; Brain Chemistry; Brain Edema; Capillaries; Chlorides; Endothelium, Vascular; Galactosamine; Intercellular Junctions; Liver Failure; Male; Microscopy, Electron; Rats; Rats, Wistar	1997
Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Hepatology (Baltimore, Md.), 1997, Volume: 25, Issue:3 Topics: Alanine Transaminase; Animals; Arginine; Aspartate Aminotransferases; Bacterial Translocation; Biology; Cecum; Colon; Colony Count, Microbial; Galactosamine; Lactobacillus; Liver Failure; Lymph Nodes; Male; Rats; Rats, Sprague-Dawley	1997
Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines. Hepatology (Baltimore, Md.), 1997, Volume: 25, Issue:4 Topics: Anesthesia; Animals; Artificial Organs; Disease Models, Animal; Dogs; Evaluation Studies as Topic; Female; Galactosamine; Liver; Liver Failure; Male; Necrosis	1997
Galactosamine-induced fulminant hepatic failure. Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:5 Topics: Animals; Disease Models, Animal; Dogs; Galactosamine; Liver Failure	1997
Oxindole, a sedative tryptophan metabolite, accumulates in blood and brain of rats with acute hepatic failure. Journal of neurochemistry, 1998, Volume: 70, Issue:5 Topics: Acute Disease; Animals; Anti-Bacterial Agents; Brain; Galactosamine; Hypnotics and Sedatives; Indoles; Liver Failure; Male; Neomycin; Oxindoles; Rats; Rats, Wistar; Thioacetamide; Tryptophan	1998
An improved model of galactosamine-induced fulminant hepatic failure in the pig. The Journal of surgical research, 1999, Volume: 82, Issue:2 Topics: Animals; Blood Coagulation Tests; Brain; Disease Models, Animal; Galactosamine; Liver; Liver Failure; Liver Function Tests; Male; Swine	1999
Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology (Baltimore, Md.), 1999, Volume: 30, Issue:1 Topics: Animals; Caspase 3; Caspases; Death; Endotoxins; Enzyme Activation; Galactosamine; Hepatocyte Growth Factor; Humans; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred C57BL; Recombinant Proteins	1999
Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccharide-induced liver injury. Life sciences, 1999, Volume: 65, Issue:4 Topics: Alanine Transaminase; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; Cell Survival; Chemical and Drug Induced Liver Injury; DNA; Drug Synergism; Galactosamine; Glucosides; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Phenols; Plant Extracts; Tumor Necrosis Factor-alpha	1999
Acute liver failure attenuates hyperacute xenograft rejection. Transplantation proceedings, 2000, Volume: 32, Issue:5 Topics: Acute Disease; Animals; Galactosamine; Graft Rejection; Graft Survival; Guinea Pigs; Heart Transplantation; Liver Failure; Male; Rats; Rats, Wistar; Transplantation, Heterologous	2000
Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2000, Volume: 14, Issue:13 Topics: Animals; Apoptosis; Cell Division; Disease Models, Animal; Galactosamine; Humans; Interleukin-6; Liver Failure; Liver Regeneration; Male; Rats; Rats, Inbred F344; Receptors, Interleukin; Receptors, Interleukin-6; Recombinant Fusion Proteins; Thioacetamide	2000
Protection against TNF-induced liver parenchymal cell apoptosis during endotoxemia by a novel caspase inhibitor in mice. Toxicology and applied pharmacology, 2000, Nov-15, Volume: 169, Issue:1 Topics: Animals; Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; DNA Fragmentation; Drug Combinations; Endotoxins; Enzyme Inhibitors; Galactosamine; Hepatocytes; Liver; Liver Failure; Male; Mice; Mice, Inbred Strains; Models, Animal; Neutrophils; Organic Chemicals; Salmonella; Tumor Necrosis Factor-alpha	2000
1,8-cineole protects against liver failure in an in-vivo murine model of endotoxemic shock. The Journal of pharmacy and pharmacology, 2001, Volume: 53, Issue:4 Topics: Animals; Cyclohexanols; Disease Models, Animal; Eucalyptol; Galactosamine; Lipopolysaccharides; Liver Failure; Male; Menthol; Mice; Monoterpenes; Shock, Septic; Solvents; Terpenes; Transaminases; Tumor Necrosis Factor-alpha	2001
Etoposide prevents apoptosis in mouse liver with D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality. Hepatology (Baltimore, Md.), 2001, Volume: 33, Issue:6 Topics: Animals; Antigens, CD; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Caspase 3; Caspase Inhibitors; Cytochrome c Group; Cytoplasm; Etoposide; Galactosamine; Hepatocytes; Lipopolysaccharides; Liver; Liver Failure; Male; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-bcl-2; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Tumor Necrosis Factor-alpha	2001
Intrahepatic amino acid and glucose metabolism in a D-galactosamine-induced rat liver failure model. Hepatology (Baltimore, Md.), 2001, Volume: 34, Issue:2 Topics: Amino Acids; Animals; Galactosamine; Glucose; In Vitro Techniques; Liver; Liver Failure; Male; Perfusion; Rats; Rats, Sprague-Dawley	2001
Effect of a herbal protein CI-1, purified from Cajanus indicus on the ultrastructural study of hepatocytes, in models of liver failure in mice. Journal of ethnopharmacology, 2001, Volume: 77, Issue:1 Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Carbon Tetrachloride; Central Nervous System Depressants; Ethanol; Fabaceae; Galactosamine; Liver; Liver Failure; Male; Mice; Phytotherapy; Plant Extracts; Plant Leaves; Plant Proteins; Plants, Medicinal	2001
A fulminant hepatic failure model in the rat: involvement of interleukin-1beta and tumor necrosis factor-alpha. Digestive diseases and sciences, 2001, Volume: 46, Issue:8 Topics: Animals; Disease Models, Animal; Galactosamine; Interleukin-1; Liver; Liver Failure; Male; Rats; Rats, Sprague-Dawley; Survival Rate; Tumor Necrosis Factor-alpha	2001
Differential protection with inhibitors of caspase-8 and caspase-3 in murine models of tumor necrosis factor and Fas receptor-mediated hepatocellular apoptosis. Toxicology and applied pharmacology, 2001, Sep-15, Volume: 175, Issue:3 Topics: Animals; Apoptosis; Blotting, Western; Caspase 3; Caspase 8; Caspase 9; Caspase Inhibitors; Cysteine Proteinase Inhibitors; DNA; DNA Fragmentation; fas Receptor; Galactosamine; Hepatocytes; Liver Failure; Male; Mice; Mice, Inbred C3H; Models, Animal; Oligopeptides; Single-Blind Method; Time Factors; Tumor Necrosis Factor-alpha	2001
Animal models of fulminant hepatic failure: need to test liver support devices. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2001, Volume: 33, Issue:7 Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Disease Models, Animal; Dogs; Galactosamine; Hepatectomy; Humans; Liver Failure; Liver Transplantation; Liver, Artificial; Swine	2001
Mechanisms of the protective effect of L-alanine to D-galactosamine-induced hepatocellular injury: comparative studies of L-alanine and pyruvate. Biochemical and biophysical research communications, 2002, Mar-08, Volume: 291, Issue:4 Topics: Alanine; Albumins; Aminoisobutyric Acids; Aminooxyacetic Acid; Animals; Cells, Cultured; Galactosamine; Hepatocytes; L-Lactate Dehydrogenase; Liver Failure; Male; Oligomycins; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley	2002
A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:3 Topics: Adenoviridae; Animals; Apoptosis; Chemical and Drug Induced Liver Injury; Cysteine Endopeptidases; Cytokines; Cytoprotection; DNA-Binding Proteins; Galactosamine; Genetic Therapy; Hepatocytes; Humans; Inflammation; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Liver Failure; Male; Mice; Mice, Inbred BALB C; NF-kappa B; Nuclear Proteins; Proteins; Receptors, Tumor Necrosis Factor; Tumor Cells, Cultured; Tumor Necrosis Factor alpha-Induced Protein 3	2002
Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model. Gut, 2002, Volume: 50, Issue:6 Topics: Animals; Bilirubin; Female; Filtration; Galactosamine; Hepatocyte Growth Factor; Liver Failure; Plasma Exchange; Plasmapheresis; Survival Analysis; Swine; Tumor Necrosis Factor-alpha	2002
Pirfenidone suppresses tumor necrosis factor-alpha, enhances interleukin-10 and protects mice from endotoxic shock. European journal of pharmacology, 2002, Jun-20, Volume: 446, Issue:1-3 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Galactosamine; Interferon-gamma; Interleukin-10; Interleukin-12; Lipopolysaccharides; Liver; Liver Failure; Mice; Mice, Inbred C57BL; Necrosis; Pyridones; Shock, Septic; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha	2002
The role of leukotriene D4 in septic shock models. Eicosanoids, 1992, Volume: 5 Suppl Topics: Animals; Cell Death; Cells, Cultured; Disease Models, Animal; Galactosamine; Lipopolysaccharides; Lipoxygenase Inhibitors; Liver; Liver Failure; Mice; Shock, Septic; SRS-A; Tumor Necrosis Factor-alpha	1992
[Therapeutic effects of epimeric glycyrrhizic acids on hepatic injury in rats]. Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1992, Volume: 13, Issue:4 Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Galactosamine; Glycyrrhetinic Acid; Glycyrrhizic Acid; Liver Failure; Male; Putrescine; Rats; Rats, Wistar; Stereoisomerism; Structure-Activity Relationship	1992
Hepatic stimulator substance from human fetal liver for treatment of experimental hepatic failure. Chinese medical journal, 1992, Volume: 105, Issue:8 Topics: Animals; Fetus; Galactosamine; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Liver; Liver Failure; Liver Regeneration; Necrosis; Peptides; Rats; Rats, Wistar	1992